摘要
目的探讨采用RevoLix2微米激光手术系统治疗前列腺增生症的疗效。方法对120例前列腺增生症患者进行了RevoLix2微米激光手术治疗,采用骶管或连续硬脊膜外阻滞麻醉。结果全部手术均成功,汽化切割时间为20～50min,平均为(37.0±10.2)min,尿管留置1～7d,平均(3.0±1.0)d,所有患者均未输血。术后随访3个月,Qmax从(6.2±3.1)mL/s增加到(19.6±1.6)mL/s(P<0.05),PVR从(132.3±102.6)mL下降到(15.6±1.6)mL(P<0.05),IPSS及QOL均有改善,分别从(25.2±3.1)分下降为(6.2±2.3)分及从(4.5±0.1)分增加到(2.2±0.2)分(P<0.05)。102例术前有性功能者,术后均保留性功能。无尿失禁发生。结论RevoLix2微米激光手术系统治疗前列腺增生症是有效和安全的,术中、术后并发症少,术后患者排尿症状及生活质量得到了明显改善,但对其长远疗效还需进一步观察。
[Objective] To evaluate the safety and efficacy of RevoLix 2 micron continuous Wave laser vaporesection of prostate for the treatment of benign prostatic hyperplasia （BPH）. [Methods] A total of 120 aged patients with BPH were treated with the RevoLix 2 micron continuous wave laser vaporesection under sacral anesthesia or continuous epidural anesthesia. [Results] The RevoLix 2 micron continuous wave laser vaporesection was successfully performed on all the 120 patients with BPH. The average vaporesection time was （37.0±10.2） minutes （range, 20-50 minutes）, catheter time was （3.0±1.0） days （range, 1 -7 days）. No patients required blood transfusion. The patients were followed up for three months. Their Qmax significantly improved from （6.2±3.1） mL/s to （19.6±1.6） mL/s（P 〈 0.05）, PVR decreased from （132.3±102.6） mL to （15.6±1.6） mL （P 〈0.05）, IPSS and QOL improved from （25,2±3.1） to （6.2±2.3） and （4.5±0.1） to （2.2±0.2） （P 〈0.05）, respectively. The 102 patients with preoperative sexual function stiU remained potent sexual function after operation. No urinary incontinence occurred. [Conclusion] RevoLix 2 micron continuous wave laser vaporesection of prostate is an excellent treatment modality for BPH, it can yield rapid, safe and effective relief for these patients, longer follow-up is needed to prove the durability of these promising results.
出处
《中国内镜杂志》
CSCD
北大核心
2009年第4期414-416,共3页
China Journal of Endoscopy
关键词
前列腺增生症
激光治疗
汽化切割
benign prostatic hyperplasia
laser treatment
vaporesection
